Signals mentioning Thyrocare
- Sterling Accuris FY26 revenue rises 16% to ₹231 crore; loss widens 38%
- PharmEasy's 2021 plan targeted $9 billion valuation in $1 billion IPO
- PharmEasy's ₹2,400 crore rights issue to repay debt resurfaces from July 2023
- PharmEasy parent API Holdings repays Rs 1,050 crore term debt, turns debt-free
- API Holdings repays ₹1,050 crore debt, releases pledge on Thyrocare stake
- PharmEasy parent API Holdings repays ₹1,050 crore debt, turns debt-free
- PharmEasy weighs renewed IPO bid as valuation resets to $2.7 billion
- PharmEasy reverse merger hinges on API Holdings turning debt-free and profitable
- Jupiter Life Line, Thyrocare see policy push on insurance and preventive tests widening healthcare demand
- Tata 1mg nears Rs 3,000 crore revenue in FY26 as diagnostics-led strategy turns profitable
- InCred CIO flags hospitals, pharma and diagnostics picks; Pine Labs remains high conviction
- Thyrocare Q1 profit rises 34% YoY to ₹51.3 crore
- Cent plans 20–25 MRI-led preventive health centres across India in 6–9 months
- Simple Energy banks Rs 250 Cr to triple store count, scale scooter output 5x before FY28 IPO
- PharmEasy parent API Holdings withdraws Rs 6,250 cr DRHP, eyes rights issue
- Orange Health Labs hits ₹180 cr ARR betting diagnostics is the next quick-commerce category
- Orange Health Labs hits ₹180 cr ARR pitching 60-min collection, 6-hr reports against Dr Lal, Metropolis
- Simple Energy raises ₹127 Cr ahead of $350 Mn FY27 IPO, plans 500-store retail push
- Simple Energy Raises ₹127 Cr Ahead of $350 Mn FY27 IPO, Targets 500-Store Rollout